Market Overview

AVANIR Pharmaceuticals Completes Public Offering of 20M Shares


AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced that it has completed the previously announced underwritten public offering of 20,000,000 shares of its common stock, offered at a price of $4.40 per share.

The net proceeds to AVANIR from the sales of shares in this offering, after deducting customary underwriting discounts and commissions, were approximately $83.2 million.

Posted-In: News Offerings


Related Articles (AVNR)

View Comments and Join the Discussion!

Get Benzinga's Newsletters